CluePoints, a provider of quality management solutions for clinical trials, launched a new Post-COVID Trial Assurance Solution. The solution offers study teams the opportunity to assess the quality of their data within a defined timeline and with limited resources. It evaluates clinical data to assess expected risks, while also identifying data anomalies that can indicate unexpected risks – surfacing issues which can be found rapidly by leveraging CluePoints’ Central Statistical Monitoring Platform.
Furthermore, CluePoints can provide Data Scientists to do all the heavy lifting and work with the study team to support plans to identify and resolve issues and document what’s been done to mitigate the risks.
“We are delighted to reveal our new CluePoints Post-COVID Trial Assurance Solution to offer continued support to the clinical research community that has been working so hard to maintain progress in developing new treatments and therapies to improve, protect, extend, and save lives during this pandemic,” says Patrick Hughes, Chief Commercial Officer and Co-Founder of CluePoints.“This new solution provides another tool in the armory for study teams to take what we have learned during the pandemic and apply it to the many ongoing trials that are still affected.”
The Post-COVID Trial Assurance Solution includes:
- Comprehensive Central Statistical Analysis: The comprehensive statistical analysis provides a complete unsupervised analysis of all clinical data to uncover unknown risks in your trial
- Key Risk Indicators (KRIs): By harnessing the power of statistical algorithms, the Key Risk Indicator module provides a convenient way to monitor how sites are performing versus the metrics that are important to the trial
- Patient Profiles: By coupling Patient Profiles with Central Statistical Monitoring, patients can be ranked by their relative degree of atypicality, allowing clinical teams to get the patients that need it reviewed faster
- Duplicate Patient Detection: If the existence of ‘Professional Patients’ participating in the trial is a concern, CluePoints’ Duplicate Patients module can identify them so that any sign of enrolment abuse can be investigated and addressed.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!